XML 16 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Investments:    
Fixed maturity available-for-sale securities, at fair value $ 81,900 $ 82,300
Trading securities 2,005 2,321
Equity securities 294 306
Mortgage loans on real estate, net of allowance for credit losses 20,940 18,873
Policy loans 2,465 2,463
Derivative investments 9,512 6,305
Other investments 6,272 4,757
Total investments 123,388 117,325
Cash and invested cash 4,505 3,193
Deferred acquisition costs, value of business acquired and deferred sales inducements 12,426 12,418
Reinsurance recoverables, net of allowance for credit losses 48,943 45,110
Deposit assets, net of allowance for credit losses 30,537 21,514
Market risk benefit assets 4,860 3,894
Accrued investment income 993 982
Goodwill 1,144 1,144
Other assets 10,192 10,139
Separate account assets 168,438 158,257
Total assets 405,426 373,976
Liabilities    
Policyholder account balances 125,818 120,316
Future contract benefits 40,002 40,174
Funds withheld reinsurance liabilities 26,810 13,628
Market risk benefit liabilities 1,046 1,716
Deferred front-end loads 6,750 5,923
Payables for collateral on investments 9,876 7,982
Short-term debt 24 840
Long-term debt 2,173 2,195
Other liabilities 13,977 12,438
Separate account liabilities 168,438 158,257
Total liabilities 394,914 363,469
Contingencies and Commitments (See Note 17)
Stockholder’s Equity    
Common stock – 10,000,000 shares authorized, issued and outstanding 13,015 12,961
Retained earnings (deficit) (173) (869)
Accumulated other comprehensive income (loss) (2,330) (1,585)
Total stockholder’s equity 10,512 10,507
Total liabilities and stockholder’s equity $ 405,426 $ 373,976